View in EDS HTML Full Text PDF Full Text

Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer.

Saved in:
Bibliographic Details
Title: Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer.
Authors: Huertas-Caro CA; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia., Ramírez MA; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia., Rey-Vargas L; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia., Bejarano-Rivera LM; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia., Ballen DF; Clinical Oncology Unit. Instituto Nacional de Cancerología and Adjunct Clinical Professor, Pontificia Universidad Javeriana, Bogotá, DC, Colombia., Nuñez M; Research Support and Follow-Up Group, National Cancer Institute of Colombia, Calle 1 No. 9 -85, Bogotá, DC, Colombia., Mejía JC; Grupo de Patología, Instituto Nacional de Cancerología, Bogotá, Colombia., Sua-Villegas LF; Department of Pathology and Laboratory Medicine, Fundación Valle del Lili, and Faculty of Health Sciences, Universidad ICESI, Cali, Colombia., Cock-Rada A; Department of Oncological Breast Surgery and Mastology, Instituto de Cancerología Las Américas, Medellín, Colombia., Zabaleta J; Department of Interdisciplinary Oncology and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA., Fejerman L; Department of Public Health Sciences, University of California Davis, Davis, CA, USA.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA., Sanabria-Salas MC; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia., Serrano-Gomez SJ; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia. silviajserrano@gmail.com.; Research Support and Follow-Up Group, National Cancer Institute of Colombia, Calle 1 No. 9 -85, Bogotá, DC, Colombia. silviajserrano@gmail.com.
Source: Scientific reports [Sci Rep] 2023 Dec 03; Vol. 13 (1), pp. 21324. Date of Electronic Publication: 2023 Dec 03.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38044375
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Huertas-Caro+CA%22">Huertas-Caro CA</searchLink>; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia.<br /><searchLink fieldCode="AU" term="%22Ramírez+MA%22">Ramírez MA</searchLink>; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia.<br /><searchLink fieldCode="AU" term="%22Rey-Vargas+L%22">Rey-Vargas L</searchLink>; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia.<br /><searchLink fieldCode="AU" term="%22Bejarano-Rivera+LM%22">Bejarano-Rivera LM</searchLink>; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia.<br /><searchLink fieldCode="AU" term="%22Ballen+DF%22">Ballen DF</searchLink>; Clinical Oncology Unit. Instituto Nacional de Cancerología and Adjunct Clinical Professor, Pontificia Universidad Javeriana, Bogotá, DC, Colombia.<br /><searchLink fieldCode="AU" term="%22Nuñez+M%22">Nuñez M</searchLink>; Research Support and Follow-Up Group, National Cancer Institute of Colombia, Calle 1 No. 9 -85, Bogotá, DC, Colombia.<br /><searchLink fieldCode="AU" term="%22Mejía+JC%22">Mejía JC</searchLink>; Grupo de Patología, Instituto Nacional de Cancerología, Bogotá, Colombia.<br /><searchLink fieldCode="AU" term="%22Sua-Villegas+LF%22">Sua-Villegas LF</searchLink>; Department of Pathology and Laboratory Medicine, Fundación Valle del Lili, and Faculty of Health Sciences, Universidad ICESI, Cali, Colombia.<br /><searchLink fieldCode="AU" term="%22Cock-Rada+A%22">Cock-Rada A</searchLink>; Department of Oncological Breast Surgery and Mastology, Instituto de Cancerología Las Américas, Medellín, Colombia.<br /><searchLink fieldCode="AU" term="%22Zabaleta+J%22">Zabaleta J</searchLink>; Department of Interdisciplinary Oncology and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.<br /><searchLink fieldCode="AU" term="%22Fejerman+L%22">Fejerman L</searchLink>; Department of Public Health Sciences, University of California Davis, Davis, CA, USA.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sanabria-Salas+MC%22">Sanabria-Salas MC</searchLink>; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia.<br /><searchLink fieldCode="AU" term="%22Serrano-Gomez+SJ%22">Serrano-Gomez SJ</searchLink>; Cancer Biology Research Group, National Cancer Institute of Colombia, Bogotá, Colombia. silviajserrano@gmail.com.; Research Support and Follow-Up Group, National Cancer Institute of Colombia, Calle 1 No. 9 -85, Bogotá, DC, Colombia. silviajserrano@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2023 Dec 03; Vol. 13 (1), pp. 21324. <i>Date of Electronic Publication: </i>2023 Dec 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38044375
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41598-023-48300-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 21324
    Titles:
      – TitleFull: Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huertas-Caro CA
      – PersonEntity:
          Name:
            NameFull: Ramírez MA
      – PersonEntity:
          Name:
            NameFull: Rey-Vargas L
      – PersonEntity:
          Name:
            NameFull: Bejarano-Rivera LM
      – PersonEntity:
          Name:
            NameFull: Ballen DF
      – PersonEntity:
          Name:
            NameFull: Nuñez M
      – PersonEntity:
          Name:
            NameFull: Mejía JC
      – PersonEntity:
          Name:
            NameFull: Sua-Villegas LF
      – PersonEntity:
          Name:
            NameFull: Cock-Rada A
      – PersonEntity:
          Name:
            NameFull: Zabaleta J
      – PersonEntity:
          Name:
            NameFull: Fejerman L
      – PersonEntity:
          Name:
            NameFull: Sanabria-Salas MC
      – PersonEntity:
          Name:
            NameFull: Serrano-Gomez SJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 12
              Text: 2023 Dec 03
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2045-2322
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Scientific reports
              Type: main
ResultId 1